Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TLR8 antisense RNA 1 (TLR8-AS1) is a long non-coding RNA transcribed from the region opposite the TLR8 gene. As a lncRNA, TLR8-AS1 does not encode a protein but may regulate the expression of TLR8 or act in the control of immune responses, inflammation, and possibly other physiological or disease processes. While the protein TLR8 itself is a well-studied receptor involved in innate immune sensing of RNA, TLR8-AS1 represents a regulatory, non-coding genetic element with emerging interest in immunology and inflammation research. There is no substantial evidence that it is a direct therapeutic target, nor that existing drugs modulate its activity, although its expression may be relevant for future biomarker or therapeutic strategies[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TLR8 antisense RNA 1 (TLR8-AS1).